Positive emotional states, not mystical experiences, may explain symptom relief in MDMA-assisted therapy for PTSD

A secondary analysis of two clinical trials suggests that positive emotional states, rather than full mystical experiences, may help explain why MDMA-assisted therapy reduces PTSD symptoms. Researchers examined 53 people with chronic, treatment-resistant PTSD who received either 75 to 125 milligrams of MDMA or a 30 to 40 milligram active placebo during two eight-hour therapy sessions. Standard-dose participants reported stronger mystical-type experiences, and 23 percent met criteria for a complete mystical experience, but overall mystical experience scores did not significantly mediate symptom improvement. The positive mood component, involving joy, peace, and love, was the only measure that reliably linked MDMA treatment with reduced PTSD severity. The findings suggest MDMA may support emotional openness, interpersonal connection, and engagement with traumatic memories rather than self-transcendence. Because the study was a modest, secondary analysis using a questionnaire designed for classic psychedelics, and the sample was overwhelmingly white, replication and MDMA-specific measures are needed.